| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/03/2011 | EP2349217A1 Novel composition based on gamma-hydroxybutyric acid |
| 08/03/2011 | EP2349206A2 Corticosteroid compositions and methods of treatments thereof |
| 08/03/2011 | EP2349203A2 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine |
| 08/03/2011 | EP2349201A1 Formulation for treatment of vaginal dryness |
| 08/03/2011 | EP2349200A1 Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 08/03/2011 | EP2069413B1 Active ingredient formulations containing comb polymers |
| 08/03/2011 | EP1878429B1 Trenadermal absorption preparation |
| 08/03/2011 | EP1758586B1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase |
| 08/03/2011 | EP1688432B1 Igm high concentration stabilized solution |
| 08/03/2011 | EP1534753B1 Peg positional isomer of an anti-tnfalpha antibody (cdp870) |
| 08/03/2011 | EP1446104B2 Spray drying methods |
| 08/03/2011 | EP1409022B1 Pharmaceutical mousse composition comprising salicylic acid |
| 08/03/2011 | EP1391202B1 Liquid drug preparations |
| 08/03/2011 | EP1317282B1 Vectors for molecule delivery to cd11b expressing cells |
| 08/03/2011 | CN1850276B Taxol polymer bond drug lyophilized powder injection and its preparing method |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102143970A Peptide analogs of alpha-melanocyte stimulating hormone |
| 08/03/2011 | CN102143762A Compounds |
| 08/03/2011 | CN102143761A Agent for treating myelofibrosis |
| 08/03/2011 | CN102143737A Method for making cetirizine tablets |
| 08/03/2011 | CN102143736A Methods for enhancing the stability of polyorthoesters and their formulations |
| 08/03/2011 | CN102140152A Antibiofouling nonionic-zwitterionic copolymer |
| 08/03/2011 | CN102139115A Preparation method for atorvastatin cyclodextrin inclusion compound and oral solid preparation thereof |
| 08/03/2011 | CN102139114A Polymer factor VIII moiety conjugates |
| 08/03/2011 | CN102139113A Novel pharmaceutical solubilization carrier and preparation method and application thereof |
| 08/03/2011 | CN102139112A Drug carrier material and preparation method and application thereof |
| 08/03/2011 | CN102139111A Water-soluble matrix and application thereof in preparation of dithranol water-soluble preparations |
| 08/03/2011 | CN102139109A Quality-stable preparation composition of angiotensin converting enzyme inhibitor |
| 08/03/2011 | CN102139108A Co-ground materials of benzimidazoles proton pump inhibitors and hydrophilic polymer auxiliary materials |
| 08/03/2011 | CN102139099A Therapeutic composition with a botulinum neurotoxin |
| 08/03/2011 | CN102139096A Injectable biological active factor composition and preparation method and application thereof |
| 08/03/2011 | CN102139079A Chinese medicinal gel for treating senile vaginitis and preparation method and application thereof |
| 08/03/2011 | CN102139074A Chinese medicinal dropping pill for treating gynecological inflammation and preparation method thereof |
| 08/03/2011 | CN102139016A Medlar floating tablet for treating chronic gastritis and preparation method thereof |
| 08/03/2011 | CN102138989A Chinese medicinal ointment for treating scalding, and preparation method and application thereof |
| 08/03/2011 | CN102138941A Precursor liposome of propolis flavone and preparation method thereof |
| 08/03/2011 | CN102138933A Production process of ferrous sulfate sustained-release tablet |
| 08/03/2011 | CN102138930A Solid preparation of compound sodium rabeprazole medicinal composition |
| 08/03/2011 | CN102138925A Tigecycline composition and preparation method thereof |
| 08/03/2011 | CN102138920A Medicinal composition containing candesartan cilexetil and hydrochlorothiazide and preparation method thereof |
| 08/03/2011 | CN102138916A Levo-gossypol for treating tumors or cyclodextrin clathrate compound of acetate thereof |
| 08/03/2011 | CN102138915A Oral medicine preparation and preparation method thereof |
| 08/03/2011 | CN102138914A Film-form preparation |
| 08/03/2011 | CN102138913A Ranitidine hydrochloride capsules and production method thereof |
| 08/03/2011 | CN102138911A Divalproex sodium sustained release tablets and preparation method thereof |
| 08/03/2011 | CN102138910A Atorvastatin calcium tablets and preparation method thereof |
| 08/03/2011 | CN102138909A Asparaginase freeze-dried powder injection and preparation method thereof, as well as asparaginase solution |
| 08/03/2011 | CN102138907A Stable rabeprazole sodium freeze-dried preparation and preparation method thereof |
| 08/03/2011 | CN102138906A Clonidine hydrochloride sustained release micropill preparation |
| 08/03/2011 | CN102138905A RhBMP-2-loaded chitosan microspheres, preparation method thereof and application thereof |
| 08/03/2011 | CN102138904A Self-solidified microspheres and preparation method and application thereof |
| 08/03/2011 | CN102138902A Inhalation composition |
| 08/03/2011 | CN102138900A Solid preparation of oxapium iodide liposome |
| 08/03/2011 | CN102138899A Olmesartan liposome solid preparation |
| 08/03/2011 | CN102138898A Nanometer liposome serving as antitumor medicament |
| 08/03/2011 | CN102138897A Composition preparation of lomefloxacin compound and sodium chloride and preparation method thereof |
| 08/03/2011 | CN102138896A Clofarabine injection and preparation method thereof |
| 08/03/2011 | CN102138895A Eyedrops containing fasudil hydrochloride and preparation method thereof |
| 08/03/2011 | CN102138894A Stable large-capacity fasudil hydrochloride injection |
| 08/03/2011 | CN102138893A Preparation process and use of sodium lysinrofen chloride injection |
| 08/03/2011 | CN102138892A Choline alfoscerate injection preparation as well as preparation method and detection method thereof |
| 08/03/2011 | CN102138891A Ketorolac tromethamine injection |
| 08/03/2011 | CN102138890A Praziquantel transdermal preparation and applications thereof |
| 08/03/2011 | CN102138889A Targeted drug-bearing ultrasonic microbubble and preparation method thereof |
| 08/03/2011 | CN102138888A Alprostadil lipid nanosphere gel and preparation method thereof |
| 08/03/2011 | CN101889973B Itraconazole gel for dogs and preparation method thereof |
| 08/03/2011 | CN101797304B Gel for adjusting microecology in vaginas of women |
| 08/03/2011 | CN101732229B Borneol inclusion compound and preparation method thereof |
| 08/03/2011 | CN101717479B Amphiphilic gradient copolymer |
| 08/03/2011 | CN101716134B 2-methoxyestradiol transdermal liniment and 2-methoxyestradiol transdermal patch |
| 08/03/2011 | CN101690820B Nano microsphere loading with platinum-containing drugs, hydrogel coated with natural polymers and preparation method and application thereof |
| 08/03/2011 | CN101671032B Calcium silicate multi-level nano-structure mesoporous microsphere and preparation method thereof |
| 08/03/2011 | CN101618869B Method for preparing small-size meso-porous hollow carbon sphere |
| 08/03/2011 | CN101606985B Liniment for treating sheep infective pustule virus and preparation method thereof |
| 08/03/2011 | CN101590077B Compound erythromycin zinc acetate ointment for local use |
| 08/03/2011 | CN101574327B Encapsulated agglomeration of microcapsules and method for the preparation thereof |
| 08/03/2011 | CN101548983B Skin disinfectant and method of producing the same |
| 08/03/2011 | CN101491616B Preparation method of traditional Chinese medicine granules capable of relieving exterior syndrome, dispelling coldness and dispersing dampness |
| 08/03/2011 | CN101491549B Traditional Chinese medicine soft-capsule and preparation method thereof |
| 08/03/2011 | CN101270163B Single-chain fragment antibody-polypeptide amalgamation protein and uses thereof |
| 08/03/2011 | CN101244255B Thymus gland pentapeptide injection and uses thereof |
| 08/03/2011 | CN101244210B Shencao target fat eliminating essential oil |
| 08/03/2011 | CN101098703B Biodegradable linkers for molecular therapies |
| 08/02/2011 | US7989612 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 08/02/2011 | US7989588 Cell permeable peptide |
| 08/02/2011 | US7989554 Reacting polyalkylene oxide with base, tertiary alkyl haloacetate, then acid to prepare polyalkylene oxide carboxylic acid |
| 08/02/2011 | US7989490 Injectable formulations of taxanes for cad treatment |
| 08/02/2011 | US7989434 Heterocyclic self-immolative linkers and conjugates |
| 08/02/2011 | US7989432 Micelles |
| 08/02/2011 | US7989414 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 08/02/2011 | US7989188 Conjugates for cancer therapy and diagnosis |
| 08/02/2011 | US7988999 Drug with enteric coating; oral administering |
| 08/02/2011 | US7988997 Matrix of water soluble polymer; solidificated foam |
| 08/02/2011 | US7988991 Adhesive patch |
| 08/02/2011 | US7988989 Nutritional product for enhancing growth and/or strengthening the immune system of equine foals |
| 08/02/2011 | US7988969 Treatment for central nervous system disorders |
| 08/02/2011 | US7988962 Use of polysulphated alginate in cellular matrices |
| 08/02/2011 | US7988956 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 08/02/2011 | US7988952 Condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns |
| 08/02/2011 | US7988685 Hydrogel compositions, devices, and microscale components |